Pyrithioxine and hypoglycemic autoimmune syndrome.
Canivet
B
B
Archambeaud
F
F
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D001323:Autoantibodies / Q000096:biosynthesis; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D007328:Insulin / Q000276:immunology; D011746:Pyrithioxin / Q000009:adverse effects* / Q000276:immunology
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D007328:Insulin; D011746:Pyrithioxin